(1,5-diphenyl-1 H -pyrazol-3-yl)oxadiazole derivatives,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S406000, C548S143000, C548S364100

Reexamination Certificate

active

07632852

ABSTRACT:
The invention relates to compounds having formula (I):Wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to a method of preparing said compounds and to the application thereof in therapeutics.

REFERENCES:
patent: 7183306 (2007-02-01), Shirai et al.
patent: 2004/0116475 (2004-06-01), Shirai et al.
patent: WO 98/32441 (1998-07-01), None
patent: WO 03/088968 (2003-10-01), None
patent: WO 2004/035566 (2004-04-01), None
patent: WO 2005/000820 (2005-01-01), None
Vippagunta et al., Advanced Drug Delivery Reviews, p. 1.
Vippagunta et al., Advanced Drug Delivery Reviews, vol. 48, p. 3-26, (2001).
Maslivets, A. N., et. al., Five-Membered 2,3-Dioxoheterocycles. XI. Synthesis and Chemical Transformations of the Beta-Aroylhydrazides of Aroylpyruvic acids, J. Org. Chem. USSR. vol. 25, No. 5, (1989) pp. 935-940.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

(1,5-diphenyl-1 H -pyrazol-3-yl)oxadiazole derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (1,5-diphenyl-1 H -pyrazol-3-yl)oxadiazole derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (1,5-diphenyl-1 H -pyrazol-3-yl)oxadiazole derivatives,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4124841

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.